Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Journal of Orthopaedic Trauma|January 10, 2020
Cost-Effectiveness of Operative Versus Nonoperative Management of Patients With Intra-articular Calcaneal FracturesStephanie R Albin, Brandon K Bellows, Drew H Van Boerum, et al.
Journal of the American Heart Association|May 18, 2022
Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US AdultsBrandon K Bellows, Amit V Khera, Yiyi Zhang, et al.
JAMA Network Open|April 7, 2026
Traditional and Emerging Lipid Markers for Cardiovascular Risk Assessment in Young vs Older AdultsRui Tang, Jaejin An, Brandon K Bellows, et al.
Journal of Human Hypertension|July 4, 2026
Patient out-of-pocket costs for antihypertensive single pill combination products with cost capsCatherine G Derington, Kyle Tong, Joshua A Jacobs, et al.
Cannabis and Cannabinoid Research|April 5, 2019
A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic PainGriffin A Tyree, Reith Sarkar, Brandon K Bellows, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|December 22, 2022
The Health and Economic Impact of Using a Sugar Sweetened Beverage Tax to Fund Fruit and Vegetable Subsidies in New York City: A Modeling StudyZhouyang Lou, Stella S Yi, Jennifer Pomeranz, et al.
Journal of the American Heart Association|February 8, 2025
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk PredictionHui Zhou, Yiyi Zhang, Matt M Zhou, et al.
Journal of the American Heart Association|July 23, 2020
Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure ControlKelsey B Bryant, James P Sheppard, Natalia Ruiz-Negrón, et al.
Circulation|February 21, 2020
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid CardiomyopathyDhruv S Kazi, Brandon K Bellows, Suzanne J Baron, et al.
Medrxiv : the Preprint Server for Health Sciences|January 18, 2024
Projected Impact of Nonpharmacologic Management of Stage 1 Hypertension Among Lower-Risk US AdultsKendra D Sims, Pengxiao Carol Wei, Joanne M Penko, et al.
Pageof 10